Skip to main content
Home

Main navigation

  • About INB
  • Nodes
  • Resources
  • Events
  • Jobs
  • News
  • TransBioNet
  • Elixir
  1. Home
  2. News
News heading Tags Posted on
PerMedCoE: Exascale-ready cell-level simulations for European Personalised Medicine INB, ELIXIR 08 Oct 20
Viral Beacon: A beacon in the ocean of SARS-CoV-2 data INB, ELIXIR 05 Oct 20
INB/ELIXIR Spain upgrades 3DBionotes tool COVID-19 edition INB, ELIXIR 13 Jul 20
INB/ELIXIR Spain launches tool to study the 3D structure of SARS-CoV-2 proteins INB, ELIXIR 04 May 20
Pre-matrícula abierta para el IV Máster en Bioinformática Aplicada a la Medicina Personalizada y la Salud del ISCIII INB 16 Apr 20
INB/ELIXIR-ES nodes and TransBioNet members effort on COVID-19 research INB, ELIXIR, TransBioNet 07 Apr 20
Researchers sound alarm on European data law INB 04 Dec 19
Women researchers and directives explain the latest advances in artificial intelligence, big data and other technologies used in biomedical research INB 26 Nov 19
La red de bioinformática traslacional TransBioNet reúne en INCLIVA a un destacado grupo de expertos en Medicina de Precisión a nivel nacional TransBioNet 22 Nov 19
Pre-matrícula abierta para el Máster en Bioinformática Aplicada a la Medicina Personalizada y la Salud del ISCIII 04 Jul 19

Pagination

  • Previous page ‹‹
  • Next page ››
Twitter Linkedin Contact
Logos
Logos
The Spanish National Bioinformatics Institute (INB), the ELIXIR Spanish Node (ELIXIR-ES), is funded through the Data Science programme (IMPaCT-Data) from the Spanish National Infrastructure for Personalized Medicine associated with Science and Technology (IMPaCT). IMPaCT-Data is funded by the National Institute of Health Carlos III (ISCIII) under exp. IMP/000019 and co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”).

User account menu

  • Log in